Tuesday, September 20, 2016

BRIEF-Can-Fite reports new data on CF102'S liver protective & regenerative properties published in scientific journal

* CF102 is currently in global phase II trial for liver

cancer and preparing for phase II trial in Nash

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)